Tea Pemovska has been awarded the Biomedicum Helsinki Young Scientist Special Prize.
Tea Pemovska defended her thesis entitled “Individualized chemical systems medicine of acute and chronic myeloid leukemia” only three weeks ago. The main aim of her thesis work was to develop a method for drug sensitivity testing that could be used to functionally profile leukaemia patients’ cells in order to identify personalised therapy options. The work was done at FIMM under the supervision of FIMM-EMBL Group Leader Krister Wennerberg and Prof. Kimmo Porkka (Helsinki University Hospital Comprehensive Cancer Center).
The thesis consists of three publications, published in exceptionally high-profile journals including Nature and Cancer Discovery. The publications describe the drug sensitivity testing method as well as the “Individualized Systems Medicine” approach developed by the Personalised Medicine Grand Challenge team at FIMM in collaboration with the haematologists of the Comprehensive Cancer Center.
Tea Pemovska will start as a Postdoctoral Researcher at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in the group of Giulio Superti-Furga, in February.